Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This study is a multi-center phase 3 trial to evaluate a treatment strategy for selecting
patients who can benefit from the synchronous resection of primary pancreatic cancer and
liver oligometastasis after induction chemotherapy. Half of participants who meet the entry
criterion will receive surgical intervention, while the other half will continue to receive
standard chemotherapy.